BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20230463)

  • 21. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging.
    Chalil S; Stegemann B; Muhyaldeen S; Khadjooi K; Smith RE; Jordan PJ; Leyva F
    J Am Coll Cardiol; 2007 Jul; 50(3):243-52. PubMed ID: 17631217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation rate and the optimal interventricular interval during cardiac resynchronization therapy in patients with chronic atrial fibrillation.
    van Gelder BM; Meijer A; Bracke FA
    Pacing Clin Electrophysiol; 2008 May; 31(5):569-74. PubMed ID: 18439170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. If it is not broken, don't fix it: avoidance of right ventricular pacing in cardiac resynchronization therapy.
    Birnie DH; Tang AS
    J Cardiovasc Electrophysiol; 2007 May; 18(5):505-6. PubMed ID: 17403083
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Avoidance of right ventricular pacing in cardiac resynchronization therapy improves right ventricular hemodynamics in heart failure patients.
    Lee KL; Burnes JE; Mullen TJ; Hettrick DA; Tse HF; Lau CP
    J Cardiovasc Electrophysiol; 2007 May; 18(5):497-504. PubMed ID: 17428272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of adrenomedullin and atrial natriuretic peptide in patients with congestive heart failure of various etiologies.
    Randa Abdel Kader M; Grace BD; Badawi NE
    Ital J Biochem; 2007 Mar; 56(1):18-27. PubMed ID: 17511350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between plasma adrenomedullin concentration and systolic time intervals during static handgrip in patients with heart failure.
    Krzemiński K; Cybulski G; Nazar K
    Clin Physiol Funct Imaging; 2009 Apr; 29(2):114-22. PubMed ID: 19207415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.
    Fruhwald FM; Fahrleitner-Pammer A; Berger R; Leyva F; Freemantle N; Erdmann E; Gras D; Kappenberger L; Tavazzi L; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jul; 28(13):1592-7. PubMed ID: 17298973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress in cardiovascular disease: technical considerations in cardiac resynchronization therapy.
    Gassis SA; Delurgio DB; Leon AR
    Prog Cardiovasc Dis; 2006; 48(4):239-55. PubMed ID: 16517246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels.
    Hessel MH; Bleeker GB; Bax JJ; Henneman MM; den Adel B; Klok M; Schalij MJ; Atsma DE; van der Laarse A
    Eur J Heart Fail; 2007 Oct; 9(10):1058-63. PubMed ID: 17728181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recoordination rather than resynchronization predicts reverse remodeling after cardiac resynchronization therapy.
    Wang CL; Wu CT; Yeh YH; Wu LS; Chang CJ; Ho WJ; Hsu LA; Luqman N; Kuo CT
    J Am Soc Echocardiogr; 2010 Jun; 23(6):611-20. PubMed ID: 20418055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy.
    Michelucci A; Ricciardi G; Sofi F; Gori AM; Pirolo F; Pieragnoli P; Giaccardi M; Colella A; Porciani MC; Di Biase L; Padeletti L; Abbate R; Gensini GF
    J Card Fail; 2007 Apr; 13(3):207-10. PubMed ID: 17448418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac contractility modulation in non-responders to cardiac resynchronization therapy.
    Nägele H; Behrens S; Eisermann C
    Europace; 2008 Dec; 10(12):1375-80. PubMed ID: 18776196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging.
    Yu CM; Zhang Q; Fung JW; Chan HC; Chan YS; Yip GW; Kong SL; Lin H; Zhang Y; Sanderson JE
    J Am Coll Cardiol; 2005 Mar; 45(5):677-84. PubMed ID: 15734610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiac resynchronization therapy by biventricular pacing. How many patients with left ventricular dysfunction are eligible?].
    Yang A; Wolpert C; Schimpf R; Schulz T; Krause U; Jung W; Herwig S; Jeong KM; Omran H; Lewalter T; Lüderitz B
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2259-63. PubMed ID: 12397540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac resynchronization therapy.
    Kass DA
    J Cardiovasc Electrophysiol; 2005 Sep; 16 Suppl 1():S35-41. PubMed ID: 16138884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy.
    Shalaby A; El-Saed A; Voigt A; Albany C; Saba S
    Pacing Clin Electrophysiol; 2008 May; 31(5):575-9. PubMed ID: 18439171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of QRS morphology in determining the prevalence of mechanical dyssynchrony in heart failure patients eligible for cardiac resynchronization: particular focus on patients with right bundle branch block with and without coexistent left-sided conduction defects.
    Haghjoo M; Bagherzadeh A; Farahani MM; Haghighi ZO; Sadr-Ameli MA
    Europace; 2008 May; 10(5):566-71. PubMed ID: 18390536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling.
    Lilli A; Ricciardi G; Porciani MC; Perini AP; Pieragnoli P; Musilli N; Colella A; Del Pace S; Michelucci A; Turreni F; Sassara M; Achilli A; Barold SS; Padeletti L
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1349-55. PubMed ID: 17976098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.